Playback speed
10 seconds
Diminishing Returns after a Fixed Duration of Immunotherapy Treatment in Advanced NSCLC?
By
Beacon Medical Interchange
FEATURING
Jack West
By
Beacon Medical Interchange
FEATURING
Jack West
5 views
November 2, 2018
Dr. Jack West reviews the important, clinically relevant results of the CheckMate-153 trial that asks ...
read more ↘ whether there is a value in continuing an immune checkpoint inhibitor in patients with advanced NSCLC doing well on immunotherapy.
↖ read less
read more ↘ whether there is a value in continuing an immune checkpoint inhibitor in patients with advanced NSCLC doing well on immunotherapy.
↖ read less
Login to view comments.
Click here to Login
Lung